<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>the akampioneer</title>
	<atom:link href="http://akampioneer.com/feed" rel="self" type="application/rss+xml" />
	<link>http://akampioneer.com</link>
	<description></description>
	<lastBuildDate>Thu, 02 Feb 2012 19:00:15 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
		<item>
		<title>Food for Thought: &#8220;Forget Alzheimer&#8217;s&#8221;? &#8211; A Book Review</title>
		<link>http://akampioneer.com/food-for-thought/food-for-thought-forget-alzheimers-a-book-review.html</link>
		<comments>http://akampioneer.com/food-for-thought/food-for-thought-forget-alzheimers-a-book-review.html#comments</comments>
		<pubDate>Thu, 02 Feb 2012 11:10:09 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Food for Thought]]></category>
		<category><![CDATA[Alzheimer' Disease]]></category>
		<category><![CDATA[book review]]></category>
		<category><![CDATA[Cornelia Stolze]]></category>
		<category><![CDATA[Early Onset Familial Alzheimer's disease]]></category>
		<category><![CDATA[EOFAD]]></category>
		<category><![CDATA[FAD]]></category>
		<category><![CDATA[Familial Alzheimer's disease]]></category>
		<category><![CDATA[National Institute of Aging]]></category>
		<category><![CDATA[NIA]]></category>
		<category><![CDATA[Probiodrug]]></category>
		<category><![CDATA[Vergiss Alzheimer]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=1999</guid>
		<description><![CDATA[&#8220;Forget Alzheimer&#8217;s&#8221; is the title and the message of a book by German journalist Cornelia Stolze who is claiming to tell the &#8220;truth about a disease which isn&#8217;t one&#8221; (Cornelia Stolze, Vergiss Alzheimer. Die Wahrheit über eine Krankheit, die keine ist, Köln/Cologne 2011: Kiepenheuer &#38; Witsch). The book is strongly criticizing the handling of dementia, [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/food-for-thought/food-for-thought-forget-alzheimers-a-book-review.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News: Anergis Appoints Jacques-François Martin as Chairman of the Board of Directors</title>
		<link>http://akampioneer.com/company-news/company-news-anergis-appoints-jacques-francois-martin-as-chairman-of-the-board-of-directors.html</link>
		<comments>http://akampioneer.com/company-news/company-news-anergis-appoints-jacques-francois-martin-as-chairman-of-the-board-of-directors.html#comments</comments>
		<pubDate>Wed, 01 Feb 2012 09:02:20 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Company News]]></category>
		<category><![CDATA[allergies]]></category>
		<category><![CDATA[allergy vaccines]]></category>
		<category><![CDATA[AllerT]]></category>
		<category><![CDATA[Anergis]]></category>
		<category><![CDATA[Chairman of the Board of Directors]]></category>
		<category><![CDATA[Chiron Vaccines]]></category>
		<category><![CDATA[Contiguous Overlapping Peptides (“COPs”)]]></category>
		<category><![CDATA[desensibilization]]></category>
		<category><![CDATA[Jacques-François Martin]]></category>
		<category><![CDATA[Markus Hosang]]></category>
		<category><![CDATA[Mymetics Corporation]]></category>
		<category><![CDATA[Pasteur-Mérieux]]></category>
		<category><![CDATA[The Vaccine Fund]]></category>
		<category><![CDATA[Vincent Charlon]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=2025</guid>
		<description><![CDATA[Anergis, a clinical-stage biopharmaceutical company developing novel allergy vaccines, today announced the appointment of Jacques-François Martin, Chairman and CEO of vaccine company Mymetics, as Chairman of the Board of Directors. Anergis develops allergy vaccines based on its proprietary technology of “Contiguous Overlapping Peptides” (“COPs”). Anergis’ lead allergy vaccine, called “AllerT”, is in clinical Phase IIb [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/company-news/company-news-anergis-appoints-jacques-francois-martin-as-chairman-of-the-board-of-directors.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News: bubbles &amp; beyond presents product update and outlook at nanotech 2012</title>
		<link>http://akampioneer.com/company-news/company-news-bubbles-beyond-presents-product-update-and-outlook-at-nanotech-2012.html</link>
		<comments>http://akampioneer.com/company-news/company-news-bubbles-beyond-presents-product-update-and-outlook-at-nanotech-2012.html#comments</comments>
		<pubDate>Mon, 30 Jan 2012 10:20:46 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Company News]]></category>
		<category><![CDATA[bubbles & beyond]]></category>
		<category><![CDATA[cleaning]]></category>
		<category><![CDATA[cosmetics]]></category>
		<category><![CDATA[enpurex(R)]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[industrial applications]]></category>
		<category><![CDATA[intelligent fluids(R)]]></category>
		<category><![CDATA[JNC-CHISSO]]></category>
		<category><![CDATA[microelectronics]]></category>
		<category><![CDATA[milestones]]></category>
		<category><![CDATA[nanotech 2012]]></category>
		<category><![CDATA[outlook]]></category>
		<category><![CDATA[phase fluids]]></category>
		<category><![CDATA[printing industry]]></category>
		<category><![CDATA[product update]]></category>
		<category><![CDATA[protecting]]></category>
		<category><![CDATA[Rolf Meyer GmbH]]></category>
		<category><![CDATA[surface modification]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=2014</guid>
		<description><![CDATA[bubbles &#38; beyond, a technology company focusing on customized intelligent fluids®, today announced that the company will present its current product portfolio and business strategy for 2012 at the upcoming nanotech 2012 conference in Tokyo, Japan (Feb. 15-17). Intelligent fluids® are customized phase fluids, which are primarily designed for cleaning, separating and protecting surfaces. They [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/company-news/company-news-bubbles-beyond-presents-product-update-and-outlook-at-nanotech-2012.html/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Company News: Amgen to Acquire Micromet</title>
		<link>http://akampioneer.com/company-news/company-news-amgen-to-acquire-micromet.html</link>
		<comments>http://akampioneer.com/company-news/company-news-amgen-to-acquire-micromet.html#comments</comments>
		<pubDate>Thu, 26 Jan 2012 13:12:08 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Company News]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=2006</guid>
		<description><![CDATA[Amgen (NASDAQ: AMGN) and Micromet, Inc. (NASDAQ: MITI) today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded inGermany with its research and development (R&#38;D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash. The transaction, which values Micromet at approximately $1.16 billion, was unanimously approved by [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/company-news/company-news-amgen-to-acquire-micromet.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>akampion Meets&#8230;. Victoria English, Co-Founder and Editor of MedNous</title>
		<link>http://akampioneer.com/akampion-meets/akampion-meets-victoria-english-co-founder-and-editor-of-mednous.html</link>
		<comments>http://akampioneer.com/akampion-meets/akampion-meets-victoria-english-co-founder-and-editor-of-mednous.html#comments</comments>
		<pubDate>Thu, 19 Jan 2012 09:49:22 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[akampion Meets...]]></category>
		<category><![CDATA[Critical Path]]></category>
		<category><![CDATA[DowJones]]></category>
		<category><![CDATA[EMEA]]></category>
		<category><![CDATA[European Commission]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Informa]]></category>
		<category><![CDATA[Innovative Medicines Initiative]]></category>
		<category><![CDATA[McGraw Hill]]></category>
		<category><![CDATA[MedNous]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Victoria English]]></category>
		<category><![CDATA[William Ellington]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=1735</guid>
		<description><![CDATA[In 2006, long-time journalists Victoria English and William Ellington decided to quit their jobs and to establish their own publication, the biomedical trade journal MedNous (pronounced Med-Nows). A year later, in September 2007, the first issue appeared alongside with the website www.mednous.com. akampion: Why did you establish MedNous? Victoria English: Both of us thought Europe’s [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/akampion-meets/akampion-meets-victoria-english-co-founder-and-editor-of-mednous.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

